Redx Pharma Crecimiento futuro
Future controles de criterios 0/6
Redx Pharma's revenue and earnings are forecast to decline at 37.6% and 22.3% per annum respectively while EPS is expected to decline by 14.2% per annum.
Información clave
-22.3%
Tasa de crecimiento de los beneficios
-14.2%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Pharmaceuticals | 18.2% |
| Tasa de crecimiento de los ingresos | -37.6% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 02 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 9/30/2025 | N/A | -49 | N/A | -48 | 1 |
| 9/30/2024 | 13 | -26 | N/A | -24 | 1 |
| 9/30/2023 | 4 | -33 | -35 | -35 | N/A |
| 6/30/2023 | 8 | -31 | -32 | -32 | N/A |
| 3/31/2023 | 13 | -29 | -30 | -30 | N/A |
| 12/31/2022 | 16 | -24 | -19 | -19 | N/A |
| 9/30/2022 | 19 | -18 | -9 | -8 | N/A |
| 6/30/2022 | 17 | -18 | -8 | -8 | N/A |
| 3/31/2022 | 16 | -19 | -8 | -7 | N/A |
| 12/31/2021 | 13 | -20 | -15 | -14 | N/A |
| 9/30/2021 | 10 | -22 | -22 | -21 | N/A |
| 6/30/2021 | 8 | -20 | -15 | -14 | N/A |
| 3/31/2021 | 7 | -18 | -7 | -7 | N/A |
| 12/31/2020 | 6 | -14 | -4 | -3 | N/A |
| 9/30/2020 | 6 | -9 | 0 | 0 | N/A |
| 6/30/2020 | 5 | -8 | -2 | -2 | N/A |
| 3/31/2020 | 4 | -6 | -5 | -5 | N/A |
| 12/31/2019 | 4 | -5 | -5 | -5 | N/A |
| 9/30/2019 | 3 | -4 | -5 | -5 | N/A |
| 6/30/2019 | 2 | -5 | -6 | -6 | N/A |
| 3/31/2019 | N/A | -7 | -8 | -8 | N/A |
| 12/31/2018 | 0 | -8 | -13 | -13 | N/A |
| 9/30/2018 | 0 | -9 | -17 | -17 | N/A |
| 6/30/2018 | 15 | -1 | -4 | -4 | N/A |
| 3/31/2018 | 31 | 8 | 9 | 9 | N/A |
| 12/31/2017 | 31 | 5 | 11 | 11 | N/A |
| 9/30/2017 | 30 | 2 | 14 | 14 | N/A |
| 6/30/2017 | 15 | -9 | N/A | -1 | N/A |
| 3/31/2017 | N/A | -19 | N/A | -16 | N/A |
| 12/31/2016 | N/A | -17 | N/A | -14 | N/A |
| 9/30/2016 | N/A | -16 | N/A | -13 | N/A |
| 6/30/2016 | N/A | -14 | N/A | -11 | N/A |
| 3/31/2016 | N/A | -12 | N/A | -9 | N/A |
| 12/31/2015 | N/A | -10 | N/A | -8 | N/A |
| 9/30/2015 | N/A | -8 | N/A | -7 | N/A |
| 6/30/2015 | N/A | -7 | N/A | -6 | N/A |
| 3/31/2015 | N/A | -5 | N/A | -5 | N/A |
| 12/31/2014 | N/A | -4 | N/A | -4 | N/A |
| 9/30/2014 | N/A | -3 | N/A | -2 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: REDX is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: REDX is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: REDX is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: REDX's revenue is expected to decline over the next 3 years (-37.6% per year).
Ingresos de alto crecimiento: REDX's revenue is forecast to decline over the next 3 years (-37.6% per year).
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if REDX's Return on Equity is forecast to be high in 3 years time